Adrian Adams
2017 - Aralez Pharmaceuticals
In 2017, Adrian Adams earned a total compensation of $2.1M as Chief Executive Officer at Aralez Pharmaceuticals, a 74% decrease compared to previous year.
Compensation breakdown
Option Awards | $228,005 |
---|---|
Salary | $721,000 |
Stock Awards | $1,138,108 |
Other | $12,000 |
Total | $2,099,113 |
Adams received $1.1M in stock awards, accounting for 54% of the total pay in 2017.
Adams also received $228K in option awards, $721K in salary and $12K in other compensation.
Rankings
In 2017, Adrian Adams' compensation ranked 5,273rd out of 14,666 executives tracked by ExecPay. In other words, Adams earned more than 64.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,273 out of 14,666 | 64th |
Division Manufacturing | 1,881 out of 5,772 | 67th |
Major group Chemicals And Allied Products | 557 out of 2,075 | 73rd |
Industry group Drugs | 430 out of 1,731 | 75th |
Industry Pharmaceutical Preparations | 339 out of 1,333 | 75th |
Source: SEC filing on May 18, 2018.
Adams' colleagues
We found five more compensation records of executives who worked with Adrian Adams at Aralez Pharmaceuticals in 2017.
2017
Scott Charles
Aralez Pharmaceuticals
Chief Financial Officer
2017
Andrew Koven
Aralez Pharmaceuticals
President and Chief Business Officer
2017
James Tursi
Aralez Pharmaceuticals
Chief Medical Officer
2017
Mark Glickman
Aralez Pharmaceuticals
Former Chief Commercial Officer
2017
Michael Kaseta
Aralez Pharmaceuticals